Inhibrx Inc. (INBX): Price and Financial Metrics Recent IPO
INBX Price/Volume Stats
| Current price | $13.83 | 52-week high | $18.95 |
| Prev. close | $14.33 | 52-week low | $10.80 |
| Day low | $12.25 | Volume | 178,200 |
| Day high | $14.77 | Avg. volume | 140,574 |
| 50-day MA | $15.75 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 200.20M |
INBX Stock Price Chart Interactive Chart >
Inhibrx Inc. (INBX) Company Bio
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology, orphan diseases and infectious diseases. Inhibrx has collaborations with Celgene and bluebird bio and has received awards from several granting agencies, including NIH, NIAID and CARB-X.
INBX Price Returns
| 1-mo | -13.56% |
| 3-mo | 6.80% |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...